A Pharmacovigilance Study on Anti-Diabetic Medications

Abstract

Introduction: The name "pharmacovigilance" comes from the Latin word "vigilare," which means "monitoring," and the Greek word "pharmakon," which means "medication." Pharmacovigilance is also called the drug safety department because it ensures the safe use of medicines. The healthcare system relies heavily on pharmacovigilance [PV], which assesses, tracks, and detects drug interactions and their impact on people. The purpose of pharmaceutical and biotechnology products is to identify, cure illnesses. Over a billion people could use drugs in India, the second most populated country in the world. Objectives: The goal of the current study was to track Adverse Drug Reactions (ADRs) linked to medications used to treat diabetes. Materials and Methods: A questionnaire-based ADRs monitoring form created in Google Form was used in the study, which was carried out through one-on-one patient interactions. Results: A total of 94 ADRs were observed in 102 prescriptions of anti-diabetic patients (55 males and 47 females). Out of 94 ADRs, the age group of patients from 40-to 50 was (n=36). Out of 94 ADRs, 35.3% were moderate. Conclusion: Metformin was the drug associated with maximum ADRs. (n=12), other groups associated with ADRs were beta-blocker, ACEs (Angiotensin Converting Inhibitors) and diuretics were a minimum number.